跳至主要内容
临床试验/NCT06356831
NCT06356831招募中不适用

National Registry of Surgical Treatment and Percutaneous Cryoablation of Parietal Endometriosis

Centre Hospitalier Intercommunal Creteil18 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2024年6月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
300
试验地点
18
主要终点
creation of a national registry for the removal of nodules by cryoablation or surgery for parietal endometriosis

研究概览

简要总结

National multicentric registry of a cohort of patient with suffering parietal endometriosis, carried out by a multidisciplinary radiosurgery team

详细描述

Patient who suffering of parietal endometriosis treat by cryoablation or chirurgical will be recorded in national registry. the patient will be follow during 3 years after treatement.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Presence of parietal endometriosis: with suggestive clinical and imaging criteria (MRI and ultrasound)
  • Symptomatic parietal endometriosis (VAS > 3 OR bothersome bleeding OR reported impact on quality of life)

排除标准

  • Endometriosis not affecting the anterior wall of the abdomen (as deep pelvic muscle: ilio-psoas, obturators, perineal, ischio-anal fossa)
  • Minor patient (< 18 years)
  • Pregnant patient at any trimester
  • Patient with hemostasis disorders (constitutional or acquired)
  • Patient with systemic infection or localized scar infection upon inclusion.
  • Patient with contraindications to MRI
  • Female patient with a planned medical or surgical procedure for the duration of the study that may interfere with the proper conduct of the study.
  • Patient unable to understand the information provided
  • Patient who is not affiliated to the social security system
  • Patient under curatorship or tutorship
  • Patient with a nodule of primary or secondary malignant tumor origin

结局指标

主要结局

creation of a national registry for the removal of nodules by cryoablation or surgery for parietal endometriosis

时间窗: at inclusion

number of Endometriosis 's patient treat by cryoablation or surgical

次要结局

  • Assess the quality of life between the two groups with PGIC-7 questionnaire(at inclusion,1 month, 6 months 1year 2 years and 3 years after treatmeant)
  • Assess the quality of life between the two groups with asses VAS questionnaire(at inclusion,1 month, 6 months 1year 2 years and 3 years after treatmeant)
  • Evaluate pre- and post-treatment imaging characteristics of parietal endometriosis(through study completion average 3 years)
  • Assess the complication rate between the two groups(at 1 month, 6month 1year 2 years and 3 years after treatmeant)
  • Assess the Severity of Complications according to Clavien Dindo for the surgeon(at inclusion)
  • Assess the recidivism rate at 3 years(at 3 years)
  • Characterize the epidemiology of parietal endometriosis nodules(at inclusion)
  • To assess the impact of hormone treatment on parietal endometriosis(at 1 month, 6month 1year 2 years and 3 years after treatmeant)
  • Assess the Severity of Complications according to Society (SIR) of Interventional Radiology or Cardiovascular and Interventional Radiological Society of Europe ( CIRSE) for Radiologists(at inclusion)
  • Assess the quality of life between the two groups with asses EHP-5 questionnaire(at inclusion,1 month, 6 months 1year 2 years and 3 years after treatmeant)
  • Evaluate the aesthetic impact of the treatments(at 1 month after treatmeant)
  • Evaluate signal and morphology changes on imaging MRI of parietal endometriosis nodules after cryoablation treatment(at inclusion,1 month, 6 months 1year 2 years and 3 years after treatmeant)
  • Evaluate signal and morphology changes on ultrasound imaging of parietal endometriosis nodules after cryoablation treatment(at inclusion,1 month, 6 months 1year 2 years and 3 years after treatmeant)
  • Assess the demographic distribution of parietal endometriosis(At inclusion)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (18)

Loading locations...

相似试验